About Us

Scott Megaffin

President

Industry Experience

25 years

Prior Experience

Onconova Therapeutics

Cephalon

Adolor

Yamanouchi

Bristol-Myers Squibb

Mr. Megaffin joined Churchill in 2015, bringing more than 25 years of related experience in the pharmaceutical industry.

Scott oversees the advancement of the clinical and commercial strategy, as well as corporate and business development.

Prior to joining the company, Scott was Senior Vice President of Commercial Development for Onconova Therapeutics. Scott has held positions of increasing responsibility at Cephalon, Adolor, Yamounchi and Bristol-Myers Squibb, leading five global launches within a variety of therapeutic categories including oncology, virology, critical care, anti-infectives, pain and inflammation.


CEO

22 years of experience

CSO

20 years of experience

President

25 years of experience

Senior Vice President,
Commercial

30 years of experience

Senior Vice President,
General Counsel

20 years of experience

Vice President,
Sales

30 years of experience

Vice President,
Market Access

30 years of experience

Vice President,
Marketing

30 years of experience

Executive Director,
Human Resources

20 years of experience